Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sumera Ghani"'
Autor:
Sumera Ghani, Muhammad Ahmed Saeed, Tashia Malik, Zia ud Din, Sumaira Farman Raja, Nighat Mir Ahmad
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 73, Iss 3 (2023)
Objective: To determine the short-term efficacy and safety of Secukinumab in Pakistani patients with ankylosing spondylitis and psoriatic arthritis in regular clinical practice. Study Design: Case series. Place and Duration of Study: Department
Externí odkaz:
https://doaj.org/article/e75e89c9a6144529b1b74d3c351a323b
Autor:
Tashia Malik, Muhammad Ahmed Saeed, Sumera Ghani, Nauman Ismat Butt, Sumaira Farman Raja, Nighat Mir Ahmed
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 73, Iss 3 (2023)
Objective: To determine the real-world efficacy and safety of subcutaneous Tocilizumab in patients with rheumatoid arthritis. Study Design: Case series. Place and Duration of Study: Department of Rheumatology, National Hospital and Medical Cent
Externí odkaz:
https://doaj.org/article/30f602b4ed144efa89cef3d9ac7d6997
Autor:
Wei-Li Di, Jemima E Mellerio, Catina Bernadis, John Harper, Alya Abdul-Wahab, Sumera Ghani, Magdalena Martinez-Queipo, Havinder Hara, Anne-Marie McNicol, John McGrath, Adrian J. Thrasher, Waseem Qasim
Publikováno v:
Human gene therapy. Clinical development.
Netherton syndrome (NS) is a serious inherited skin disorder caused by mutations in the gene SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal type-related inhibitor). Patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b72128eb5bcd862bffec78da227c9d
https://pubmed.ncbi.nlm.nih.gov/24138501
https://pubmed.ncbi.nlm.nih.gov/24138501
Autor:
Alan Mackay, Ian Jacobs, Sumera Ghani, Claus Høgdall, Susan J. Ramus, Susanne Kruger-Kjaer, Chris Jones, James Morris, Tanya Sher, Jan Blaakær, Simon A. Gayther, Lise Christensen, Estrid Høgdall
Publikováno v:
Cancer Research. 71:LB-319
There is a need to identify novel therapeutic targets and better prognostic markers for ovarian cancer. Previous studies have shown that somatic genetic alterations are associated with clinicopathological features of cancers, and array comparative ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c4760bf243559e2f3cb12ef1cb83cd38
https://doi.org/10.1158/1538-7445.am2011-lb-319
https://doi.org/10.1158/1538-7445.am2011-lb-319